(Reuters) – GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms […]

The US Food and Drug Administration has expanded the indication of inotuzumab ozogamicin (Besponsa, Pfizer) to include children aged ≥ 1 year with relapsed or refractory […]

An ongoing cyberattack, lasting more than 2 weeks, has had a substantial impact on cancer practices and their patients in the United States. Change Healthcare, a […]

(Reuters) -High levels of cancer-causing chemical benzene were detected in some acne treatments from brands including Estee Lauder’s Clinique, Target’s Up & Up and Reckitt Benckiser-owned […]

TOPLINE: Resecting the primary colon tumor before chemotherapy does not improve overall survival compared with chemotherapy alone in patients with metastatic colon cancer not amenable to […]

TOPLINE: Treatment modifications, such as dose reductions, schedule changes, or use of less toxic regimens, can improve how well older patients with advanced cancer and aging-related […]

As an avid student of myeloma clinical trial history, I greatly appreciate the groundwork laid by past efforts. All that hard work has helped ease my […]

TOPLINE: Bilateral oophorectomy significantly reduces the risk for early death from any cause in women with a pathogenic variant in the BRCA1/2 genes, new data confirm. […]

The US Food and Drug Administration (FDA) has granted new approvals for the use of amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) in certain patients with locally advanced […]